What is Gap Analysis in HL7 Interfacing?
August 4, 2014
First, what’s the problem? One of the problems we hear about from HL7 team leads and their management is that interfaces take a long time
First, what’s the problem? One of the problems we hear about from HL7 team leads and their management is that interfaces take a long time
Tip 21 in the Interoperability Tip Series This tip is especially relevant for Healthcare Information Exchanges (HIEs), regardless of whether your exchange is internal to
Healthcare Information Exchange Types There are three basic types of healthcare information exchanges (HIEs): some cover a geographic region (for instance, NCHIE in North Carolina),
Tip 20 in the Interoperability Tip Series In our previous tip, we explained why you need to map processes and workflows. Many developers list their
Tip 19 in the Interoperability Tip Series Throughout the Interoperability Tip Series, we’ve stressed the need to complement the message structure and and content details
Tip 18 in the Interoperability Series What’s The Big Deal? If you’re just getting your feet wet with clinical and medical applications, you might think:
Brian Ahier is right Before you read any further, please go right now and check out what health data exchange expert Brian Ahier has to
Tip 17 in the Interoperability Tip Series HL7 Data for Testing In last week’s tip on HL7 test reporting, we suggested that you use production
Over the past few weeks, we’ve reviewed multiple HL7 testing topics. So you know how critical it is to test interfaces during interface configuration, the
Tip 16 in the Interoperability Tip Series The past few tips have covered HL7 testing and test automation. This one covers what you should do
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.